According to a new report Global Contrast Injector Systems Market, published by KBV research, The Global Contrast Injector Systems Market size is expected to reach $1.03 billion by 2024, rising at a market growth of 7.9% CAGR during the forecast period.
The North America market would dominate the Global Radiology Market by Region by 2024; growing at a CAGR of 6.3 % during the forecast period. The Europe market is expected to witness a CAGR of 6.7% during (2018 - 2024). Additionally, The Asia Pacific market is expected to witness a CAGR of 8.3% during (2018 - 2024).
The Consumables market dominated the Global Contrast Injector Systems Market by Product in 2017, growing at a CAGR of 7.5 % during the forecast period. The Injector Systems market is expected to witness a CAGR of 8.2% during (2018 - 2024).
The Hospitals market dominated the Global Contrast Injector Systems Market by End User in 2017. The Diagnostics Centers market is expected to witness a CAGR of 7.1% during (2018 - 2024).
Full Report: https://www.kbvresearch.com/contrast-injector-systems-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Bayer Ag, Angiodynamics Inc., GE Healthcare (A Healthcare Division of GE Company), Medtron AG, Nemoto Kyorindo Co., Ltd., Sino Medical- Device Technology Co., Ltd., Shenzhen Seacrown Electromechanical Co., Ltd., Ulrich GmbH & Co. Kg, Vivid Imaging and Guerbet Group.
By Application
By Product
By End User
By Geography
Companies Profiled
Unique Offerings from KBV Research
Related Reports:
North America Contrast Injector Systems Market (2018-2024)
Europe Contrast Injector Systems Market (2018-2024)
Unique Offerings 
